Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
SMITH & NEPHEW PLC |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 1,035.50 GBX | +1.17% | +1.07% | -6.67% | |
| Nov. 30 | European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading | MT |
| Nov. 29 | Transcript : Smith & Nephew plc - Shareholder/Analyst Call | CI |
Financials (USD)
| Sales 2023 * | 5,545 M | Sales 2024 * | 5,813 M | Capitalization | 11.45 B |
|---|---|---|---|---|---|
| Net income 2023 * | 461 M | Net income 2024 * | 622 M | EV / Sales 2023 * | 2,52x |
| Net Debt 2023 * | 2,534 M | Net Debt 2024 * | 2,315 M | EV / Sales 2024 * | 2,37x |
| P/E ratio 2023 * | 26,9x | P/E ratio 2024 * | 19,2x | Employees | 19,000 |
| Yield 2023 * | 2,78% | Yield 2024 * | 3,02% | Free-Float | 99.31% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +1.17% | ||
| 1 week | +1.07% | ||
| Current month | +1.17% | ||
| 1 month | +12.14% | ||
| 3 months | -2.72% | ||
| 6 months | -13.82% | ||
| Current year | -6.67% |
1 week
1 012.00
1 037.50
1 month
974.781 043.50
Current year
887.001 316.75
1 year
887.001 316.75
3 years
887.001 681.50
5 years
887.002 023.00
10 years
816.502 023.00
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Nath
CEO | Chief Executive Officer | - | 2022 |
| Director of Finance/CFO | 52 | 2020 | |
Alison Parkes
CMP | Compliance Officer | - | 1999 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marc E. Owen
BRD | Director/Board Member | 64 | 2017 |
| Director/Board Member | 59 | 2014 | |
Rick Medlock
BRD | Director/Board Member | 63 | 2020 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.35% | 118 M€ | -45.65% | ||
| 1.79% | 9 M€ | -3.53% | - | |
| 1.79% | 0 M€ | 0.00% | - | |
| 1.54% | 31 M€ | +6.55% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-01 | 1,035.50 | +1.17% | 2,062,490 |
| 23-11-30 | 1,023.50 | +0.20% | 5,403,513 |
| 23-11-29 | 1,021.50 | +0.05% | 2,571,471 |
| 23-11-28 | 1,021.00 | -0.05% | 3,555,214 |
| 23-11-27 | 1,021.50 | -0.29% | 1,553,400 |
Delayed Quote London Stock Exchange, December 01, 2023 at 11:35 am EST
More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows:
- orthopedic surgery (40.5%): primarily orthopedic implants (hips, knees and shoulders) ;
- sports medicine, arthroscopy and cervicofacial surgery (30.5%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (29%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53% of net sales.
Calendar
2024-02-27
- Q4 2023 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.13USD
Average target price
16.21USD
Spread / Average Target
+23.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.67% | 11 448 M $ | |
| +21.80% | 113 B $ | |
| -47.38% | 9 012 M $ | |
| -39.76% | 4 479 M $ | |
| +49.11% | 3 176 M $ | |
| -8.06% | 2 913 M $ | |
| -4.76% | 2 783 M $ | |
| +7.49% | 2 653 M $ | |
| +19.37% | 2 356 M $ | |
| +9.49% | 2 087 M $ |
